Logo image of INCR-U.CA

Intercure Ltd (INCR-U.CA) Stock Price, Quote, News and Overview

TSX:INCR-U - Toronto Stock Exchange - IL0011063760 - Common Stock - Currency: USD

1.53  +0.06 (+4.08%)

INCR-U.CA Quote, Performance and Key Statistics

Intercure Ltd

TSX:INCR-U (8/14/2023, 7:00:00 PM)

1.53

+0.06 (+4.08%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High7.42
52 Week Low1.47
Market Cap69.73M
Shares45.57M
Float27.36M
Yearly DividendN/A
Dividend YieldN/A
PE6.12
Fwd PE3.1
Earnings (Next)N/A N/A
IPO07-26 2007-07-26


INCR-U.CA short term performance overview.The bars show the price performance of INCR-U.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

INCR-U.CA long term performance overview.The bars show the price performance of INCR-U.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of INCR-U.CA is 1.53 USD. In the past month the price decreased by -35.17%. In the past year, price decreased by -79.6%.

Intercure Ltd / INCR-U Daily stock chart

INCR-U.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.51 2.92B
CRON.CA CRONOS GROUP INC 14.94 1.04B
TLRY.CA TILRAY BRANDS INC N/A 880.42M
DHT-UN.CA DRI HEALTHCARE TRUST 6.63 783.66M
GUD.CA KNIGHT THERAPEUTICS INC 56.09 614.84M
DHT-U.CA DRI HEALTHCARE TRUST 4.81 568.88M
ACB.CA AURORA CANNABIS INC 123.4 347.06M
WEED.CA CANOPY GROWTH CORP N/A 337.86M
CPH.CA CIPHER PHARMACEUTICALS INC 24.34 311.80M
NGEN.CA NERVGEN PHARMA CORP N/A 247.83M
OGI.CA ORGANIGRAM GLOBAL INC 30.83 247.68M
HITI.CA HIGH TIDE INC N/A 243.60M

About INCR-U.CA

Company Profile

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Company Info

Intercure Ltd

Medinat HaYehudim 85

Herzliya 4676670 IL

CEO: Alexander Rabinovich

Employees: 350

INCR-U Company Website

Phone: 972774605012.0

Intercure Ltd / INCR-U.CA FAQ

What is the stock price of Intercure Ltd today?

The current stock price of INCR-U.CA is 1.53 USD. The price increased by 4.08% in the last trading session.


What is the ticker symbol for Intercure Ltd stock?

The exchange symbol of Intercure Ltd is INCR-U and it is listed on the Toronto Stock Exchange exchange.


On which exchange is INCR-U.CA stock listed?

INCR-U.CA stock is listed on the Toronto Stock Exchange exchange.


What is the price forecast or stock price prediction for Intercure Ltd stock?

8 analysts have analysed INCR-U.CA and the average price target is 0.03 USD. This implies a price decrease of -98.25% is expected in the next year compared to the current price of 1.53. Check the Intercure Ltd stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is Intercure Ltd worth?

Intercure Ltd (INCR-U.CA) has a market capitalization of 69.73M USD. This makes INCR-U.CA a Micro Cap stock.


How many employees does Intercure Ltd have?

Intercure Ltd (INCR-U.CA) currently has 350 employees.


What are the support and resistance levels for Intercure Ltd (INCR-U.CA) stock?

Intercure Ltd (INCR-U.CA) has a resistance level at 1.58. Check the full technical report for a detailed analysis of INCR-U.CA support and resistance levels.


Is Intercure Ltd (INCR-U.CA) expected to grow?

The Revenue of Intercure Ltd (INCR-U.CA) is expected to grow by 20.95% in the next year. Check the estimates tab for more information on the INCR-U.CA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Intercure Ltd (INCR-U.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Intercure Ltd (INCR-U.CA) stock pay dividends?

INCR-U.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of Intercure Ltd (INCR-U.CA)?

The PE ratio for Intercure Ltd (INCR-U.CA) is 6.12. This is based on the reported non-GAAP earnings per share of 0.25 and the current share price of 1.53 USD. Check the full fundamental report for a full analysis of the valuation metrics for INCR-U.CA.


INCR-U.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

INCR-U.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to INCR-U.CA. While INCR-U.CA is still in line with the averages on profitability rating, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INCR-U.CA Financial Highlights

Over the last trailing twelve months INCR-U.CA reported a non-GAAP Earnings per Share(EPS) of 0.25. The EPS increased by 86.38% compared to the year before.


Industry RankSector Rank
PM (TTM) 7.77%
ROA 3.62%
ROE 6.29%
Debt/Equity 0.24
Chartmill High Growth Momentum
EPS Q2Q%-98.61%
Sales Q2Q%21.72%
EPS 1Y (TTM)86.38%
Revenue 1Y (TTM)48.85%

INCR-U.CA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to INCR-U.CA. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -141.25% and a revenue growth 20.95% for INCR-U.CA


Ownership
Inst Owners3.31%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts85
Price Target0.03 (-98.04%)
EPS Next Y-141.25%
Revenue Next Year20.95%